V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250008053 | 250005546 | 1.76 | null | Palliative (P) | 2018-04-20 | 2018-04-20 | CYTARABINE | 2 | N | 250010875 | CAPECITABINE |
| 250008054 | 250005547 | 1.6 | 66 | null | 2018-06-14 | 2018-06-28 | Trial Unspecified | 02 | N | 250010991 | CARBOPLATIN + PACLITAXEL |
| 250008055 | 250009904 | 1.72 | 0 | null | 2017-08-08 | 2017-08-10 | Vinorelbine (oral) | 1 | N | 250011005 | CARBOPLATIN |
| 250008056 | 250009904 | 1.55 | null | Palliative (P) | 2017-04-28 | 2017-05-06 | CHLVPP | 2 | N | 250011005 | GEMCITABINE |
| 250008057 | 250005548 | 0 | 0 | Disease modification (D) | 2017-04-17 | 2017-05-01 | Cisplatin | N | N | 250011096 | CARBOPLATIN |
| 250008058 | 250005549 | 0 | 86 | Adjuvant (A) | 2018-12-29 | 2018-12-29 | CHOP R - 21 days | N | N | 250011190 | BENDAMUSTINE + RITUXIMAB |
| 250008059 | 250009905 | 1.6 | 69.3 | Palliative (P) | 2018-12-04 | 2018-12-04 | Trial Unspecified | 2 | N | 250011219 | VINORELBINE |
| 250008060 | 250005550 | 1.8 | 63 | Palliative (P) | 2017-08-30 | 2017-08-30 | Pemetrexed | 2 | N | 250011240 | PEMETREXED |
| 250008061 | 250005551 | null | 0 | null | 2018-06-23 | 2018-06-27 | IPM | 2 | N | 250011409 | FLAG + IDARUBICIN |
| 250008062 | 250005552 | 1.7 | 75.2 | Palliative (P) | 2018-06-13 | 2018-06-13 | Chlorambucil | 2 | N | 250011462 | GEMCARBO |
| 250008063 | 250005552 | 0 | 95.3 | Adjuvant (A) | 2018-01-14 | 2018-01-14 | IPM | 02 | N | 250011462 | TRIAL |
| 250008064 | 250005552 | 1.74 | 59.6 | Palliative (P) | null | 2015-04-20 | DA 3 + 10 | null | N | 250011462 | CAPECITABINE + OXALIPLATIN |
| 250008065 | 250005553 | 0 | 0 | Curative (C) | 2017-12-14 | 2018-03-14 | Trial Unspecified | N | N | 250011699 | AZACITIDINE |
| 250008066 | 250005554 | null | 79 | Palliative (P) | 2016-12-26 | 2016-12-26 | Cladribine (subcut) 5 days | 2 | N | 250011703 | RUXOLITINIB |
| 250008067 | 250005554 | 1.55 | 70.5 | null | null | 2018-06-07 | Pemetrexed | null | N | 250011703 | ENZALUTAMIDE |
| 250008068 | 250005555 | 1.65 | null | Palliative (P) | 2014-05-03 | 2014-05-03 | Capecitabine | 02 | null | 250012125 | SUNITINIB |
| 250008069 | 250005556 | null | 63.9 | Not known (9) | 2016-06-04 | 2016-06-17 | Trial Unspecified | N | N | 250012276 | PEMETREXED |
| 250008070 | 250005557 | 1.59 | 72.099 | Disease modification (D) | 2018-02-23 | 2018-03-20 | R GCVP | null | N | 250012283 | PEMETREXED |
| 250008071 | 250005558 | null | null | Disease modification (D) | null | 2019-02-07 | Vinorelbine (oral) | null | N | 250012306 | PEMETREXED |
| 250008072 | 250009908 | null | 0 | Curative (C) | 2014-10-29 | 2014-10-29 | Carboplatin AUC 6 - 10 | 02 | N | 250012434 | CHOP R |
| 250008073 | 250005559 | 1.77 | 80.4 | Palliative (P) | 2016-10-10 | 2016-10-16 | Bortezomib (weekly) | 2 | N | 250012636 | PEMETREXED |
| 250008074 | 250005559 | 1.87 | 82.9 | Palliative (P) | 2017-02-28 | 2017-02-28 | IPM | 1 | N | 250012636 | BORTEZOMIB |
| 250008075 | 250005560 | 0 | 58.2 | Palliative (P) | 2016-07-16 | 2016-07-16 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 250012897 | ERLOTINIB |
| 250008076 | 250005561 | null | 102.1 | null | 2017-01-21 | 2017-01-21 | Pemetrexed | N | N | 250012910 | PEMETREXED |
| 250008077 | 250005561 | 0 | 73.7 | Disease modification (D) | 2017-10-30 | 2017-10-31 | Trial Unspecified | 02 | N | 250012910 | CISPLATIN + GEMCITABINE |
| 250008078 | 250005561 | 1.6 | 67.6 | Palliative (P) | 2016-07-23 | 2016-07-28 | Carboplatin + Paclitaxel (3 weekly) | null | Y | 250012910 | GEMCARBO |
| 250008079 | 250005562 | 1.74 | 56 | Disease modification (D) | 2018-06-23 | 2018-06-24 | Pemetrexed | Y | N | 250013268 | CHOEP |
| 250008080 | 250005563 | 1.65 | 80 | Adjuvant (A) | 2016-05-16 | 2016-05-16 | Vinorelbine IV | Y | N | 250013416 | CISPLATIN |
| 250008081 | 250005564 | null | null | Palliative (P) | 2013-11-07 | 2013-11-07 | CARBOPLATIN + ETOPOSIDE | null | N | 250013473 | TRIAL |
| 250008082 | 250005564 | 1.67 | 0 | Palliative (P) | 2017-03-01 | 2017-03-01 | Trial Unspecified | 01 | N | 250013473 | TRIAL |
| 250008083 | 250005565 | null | 61.6 | Palliative (P) | 2016-09-17 | 2016-09-25 | IPM | 02 | N | 250013493 | CISPLATIN |
| 250008084 | 250005566 | 1.7 | 73.8 | Palliative (P) | 2017-01-04 | 2017-01-04 | Rituximab | 2 | N | 250013495 | CARBOPLATIN + ETOPOSIDE |
| 250008085 | 250005566 | 0 | 0 | Palliative (P) | 2018-10-22 | 2018-11-06 | Pemetrexed | 2 | N | 250013495 | CHOP R |
| 250008086 | 250005567 | 1.64 | 64 | Palliative (P) | 2016-09-30 | 2016-09-30 | Trial Unspecified | 2 | N | 250013580 | AZACITIDINE |
| 250008087 | 250005567 | 1.62 | null | Disease modification (D) | 2014-09-06 | 2014-09-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 250013580 | VINORELBINE |
| 250008088 | 250005568 | null | 43.6 | Curative (C) | 2018-05-14 | 2018-05-14 | IPM | 2 | N | 250013720 | AFLIBERCEPT + FU + IRINOTECAN |
| 250008089 | 250005569 | 1.5 | 83 | Palliative (P) | 2018-04-21 | 2018-04-21 | Trial Unspecified | N | N | 250013747 | CAPECITABINE |
| 250008090 | 250005569 | 0 | 82 | Palliative (P) | 2015-06-10 | 2015-06-17 | CARBOPLATIN + ETOPOSIDE | 02 | N | 250013747 | CYTARABINE |
| 250008091 | 250005569 | 1.69 | 73.8 | Disease modification (D) | 2016-05-18 | 2016-05-27 | Carboplatin + Vinorelbine Oral | N | N | 250013747 | CARBOPLATIN + DOCETAXEL |
| 250008092 | 250005570 | null | null | Palliative (P) | 2015-07-10 | 2015-07-16 | FLAG | N | N | 250013898 | CARBOPLATIN |
| 250008093 | 250005571 | 1.72 | null | Palliative (P) | 2019-01-22 | 2019-01-26 | Cisplatin + Paclitaxel | N | N | 250013988 | IPM |
| 250008094 | 250005572 | 1.67 | null | Curative (C) | 2016-12-27 | 2018-08-27 | HCX | N | null | 250014072 | BOSUTINIB |
| 250008095 | 250005572 | null | 75.9 | Palliative (P) | 2016-05-12 | 2016-06-19 | CHOP R - 21 days | N | N | 250014072 | IPM |
| 250008096 | 250005573 | null | 73 | null | 2018-12-09 | 2018-12-10 | Trial Unspecified | 02 | N | 250014299 | BUSULPHAN |
| 250008097 | 250005574 | 0 | 0 | Adjuvant (A) | null | 2015-01-31 | Trial Unspecified | N | N | 250014335 | CISPLATIN + PACLITAXEL |
| 250008098 | 250009916 | 1.74 | 75.1 | Palliative (P) | null | 2014-11-14 | Chlorambucil + Pred + Rituximab | N | N | 250014420 | OXALIPLATIN + MDG |
| 250008099 | 250005575 | 0 | 51.9 | Curative (C) | 2018-01-22 | 2018-02-05 | Sunitinib | 1 | N | 250014531 | TRIAL |
| 250008100 | 250005576 | 1.7 | null | Palliative (P) | 2017-11-27 | 2017-12-07 | Pemetrexed | N | N | 250014676 | CARBOPLATIN + PACLITAXEL |
| 250008101 | 250005576 | null | null | Palliative (P) | 2017-11-13 | 2017-11-13 | EOX | N | N | 250014676 | RITUXIMAB |
| 250008102 | 250011682 | 1.64 | 0 | Palliative (P) | null | 2018-04-27 | Cisplatin | N | N | 250014781 | DA |